Erratum: CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum

Theranostics. 2021 May 15;11(14):7128-7129. doi: 10.7150/thno.62534. eCollection 2021.

Abstract

[This corrects the article DOI: 10.7150/thno.51000.].

Publication types

  • Published Erratum